Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.14 +0.02 (+0.18%)
As of: Oct 2, 2026 · 2:44 PM EDT

Biocryst Pharmaceuticals (BCRX) Net Equity Issued and Repurchased (2010 - 2026)

Updated

Biocryst Pharmaceuticals' Net Equity Issued and Repurchased came in at $6.2 million for Q2 2026, up 81.3% from $3.42 million a year earlier but down 68.2% from the prior quarter.

Analysis

Biocryst Pharmaceuticals (BCRX) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Biocryst Pharmaceuticals reported Net Equity Issued and Repurchased of $28.99 million, up 296.5% year-over-year; for FY2025, it was $9.12 million, up 164.7% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -37.2% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $3.44 million in FY2024 (-58.7%), $8.34 million in FY2023 (-43.5%), $14.77 million in FY2022 (-70.5%) and $50 million in FY2021 (-46.4%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is -$586,000 (Q4 2024) to $37.75 million (Q4 2021).
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2026 (growth of 715.0%), and the weakest in Q4 2023 (a decline of 99.0%).
  • Business Quant data shows BCRX's Net Equity Issued and Repurchased at $19.48 million (Q1 2026), $657,000 (Q4 2025) and $2.65 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Biocryst Pharmaceuticals 2.13 Bn 1.05 Bn 214.41 Mn 6.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.20 Mn
Mar 31, 2026 19.48 Mn
Dec 31, 2025 657,000.00
Sep 30, 2025 2.65 Mn
Jun 30, 2025 3.42 Mn
Mar 31, 2025 2.39 Mn
Dec 31, 2024 -586,000.00
Sep 30, 2024 2.09 Mn
Jun 30, 2024 264,000.00
Mar 31, 2024 1.68 Mn
Dec 31, 2023 39,000.00
Sep 30, 2023 1.48 Mn
Jun 30, 2023 1.75 Mn
Mar 31, 2023 5.08 Mn
Dec 31, 2022 4.01 Mn
Sep 30, 2022 3.25 Mn
Jun 30, 2022 147,000.00
Mar 31, 2022 7.36 Mn
Dec 31, 2021 37.75 Mn
Sep 30, 2021 4.78 Mn
API Access

Biocryst Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BCRX&period=max&api_key=YOUR_API_KEY